MX368985B - Compuestos novedosos de imidazobenzotiazol fusionado. - Google Patents

Compuestos novedosos de imidazobenzotiazol fusionado.

Info

Publication number
MX368985B
MX368985B MX2016012535A MX2016012535A MX368985B MX 368985 B MX368985 B MX 368985B MX 2016012535 A MX2016012535 A MX 2016012535A MX 2016012535 A MX2016012535 A MX 2016012535A MX 368985 B MX368985 B MX 368985B
Authority
MX
Mexico
Prior art keywords
compounds
novel fused
pharmaceutically acceptable
fused imidazobenzothiazole
present
Prior art date
Application number
MX2016012535A
Other languages
English (en)
Other versions
MX2016012535A (es
Inventor
Chaitanya Dutt
Vijay Chauthaiwale
Sanjay Srivastava
Shailesh Deshpande
Shinde Pundlik
Tuli Davindar
Rai Deepak
Gj Prashant
Gupta Rameshchandra
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of MX2016012535A publication Critical patent/MX2016012535A/es
Publication of MX368985B publication Critical patent/MX368985B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a derivados novedosos de imidazobenzoizol fusionados sus sales farmacéuticamente aceptables y sus isómeros, estereoisómeros, atropisómeros, confórmeros, tautómeros, hidratos, solvatos y N-óxido. La presente invención también incluye composiciones farmacéuticamente aceptables de dichos compuestos y proceso para la preparación de nuevos compuestos. La invención además se refiere al uso de los compuestos mencionados anteriormente para la preparación de medicamento para uso como farmacéuticos.
MX2016012535A 2014-03-27 2015-03-24 Compuestos novedosos de imidazobenzotiazol fusionado. MX368985B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1089MU2014 2014-03-27
PCT/IB2015/052124 WO2015145336A1 (en) 2014-03-27 2015-03-24 Novel fused imidazobenzothiazole compounds

Publications (2)

Publication Number Publication Date
MX2016012535A MX2016012535A (es) 2017-05-04
MX368985B true MX368985B (es) 2019-10-23

Family

ID=54194050

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012535A MX368985B (es) 2014-03-27 2015-03-24 Compuestos novedosos de imidazobenzotiazol fusionado.

Country Status (29)

Country Link
US (2) US9908898B2 (es)
EP (1) EP3122755B1 (es)
JP (1) JP6480949B2 (es)
KR (1) KR102339610B1 (es)
CN (1) CN106414458B (es)
AR (1) AR099867A1 (es)
AU (1) AU2015237840B2 (es)
CA (1) CA2943098C (es)
CY (1) CY1121147T1 (es)
DK (1) DK3122755T3 (es)
EA (1) EA029745B9 (es)
ES (1) ES2707099T3 (es)
HR (1) HRP20190121T1 (es)
HU (1) HUE042493T2 (es)
IL (1) IL247955B (es)
LT (1) LT3122755T (es)
MX (1) MX368985B (es)
MY (1) MY193041A (es)
PH (1) PH12016501903B1 (es)
PL (1) PL3122755T3 (es)
PT (1) PT3122755T (es)
RS (1) RS58324B1 (es)
SG (1) SG11201607793RA (es)
SI (1) SI3122755T1 (es)
TR (1) TR201900735T4 (es)
TW (1) TWI648282B (es)
UA (1) UA121469C2 (es)
WO (1) WO2015145336A1 (es)
ZA (1) ZA201606598B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105073728A (zh) 2013-03-15 2015-11-18 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
TWI648282B (zh) * 2014-03-27 2019-01-21 印度商托仁特生技有限公司 新熔合咪唑苯并噻唑化合物
DE102016209204A1 (de) 2016-05-27 2017-11-30 Robert Bosch Gmbh Vorrichtung zur Regelung mindestens eines Fluidstroms in einem Fahrzeug
KR102630959B1 (ko) * 2016-10-31 2024-01-29 엘지디스플레이 주식회사 유기 화합물과 이를 이용한 발광다이오드 및 유기발광다이오드 표시장치
CN106727538A (zh) * 2017-02-20 2017-05-31 潘连香 一种治疗2型糖尿病的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724566D0 (en) * 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
GB8908845D0 (en) * 1989-04-19 1989-06-07 Roussel Lab Ltd Chemical compounds
JPH09512548A (ja) * 1994-04-29 1997-12-16 ファルマシア・アンド・アップジョン・カンパニー レトロウイルス感染、特にｈｉｖ感染の治療のためのメタノール誘導体
AU2001294515A1 (en) * 2000-08-11 2002-02-25 The Regents Of The University Of California Use of stat-6 inhibitors as therapeutic agents
US7601846B2 (en) * 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
CA2506796A1 (en) * 2002-11-25 2004-06-10 Pharmacia Corporation Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
GB0320244D0 (en) * 2003-05-06 2003-10-01 Aventis Pharma Inc Pyrazoles as inhibitors of tumour necrosis factor
JP2009526037A (ja) * 2006-02-09 2009-07-16 ファイザー・リミテッド トリアゾロピリジン化合物
TWI648282B (zh) * 2014-03-27 2019-01-21 印度商托仁特生技有限公司 新熔合咪唑苯并噻唑化合物

Also Published As

Publication number Publication date
KR102339610B1 (ko) 2021-12-14
UA121469C2 (uk) 2020-06-10
HRP20190121T1 (hr) 2019-03-08
KR20160129089A (ko) 2016-11-08
IL247955B (en) 2021-02-28
US20170107233A1 (en) 2017-04-20
HUE042493T2 (hu) 2019-07-29
WO2015145336A1 (en) 2015-10-01
CA2943098C (en) 2022-07-05
EA029745B9 (ru) 2018-08-31
AU2015237840A1 (en) 2016-09-29
SG11201607793RA (en) 2016-10-28
CN106414458B (zh) 2019-10-29
NZ724342A (en) 2021-02-26
PH12016501903A1 (en) 2017-01-09
PL3122755T3 (pl) 2019-05-31
EA029745B1 (ru) 2018-05-31
MY193041A (en) 2022-09-23
US10227361B2 (en) 2019-03-12
RS58324B1 (sr) 2019-03-29
TW201613941A (en) 2016-04-16
LT3122755T (lt) 2019-02-11
JP2017513825A (ja) 2017-06-01
MX2016012535A (es) 2017-05-04
SI3122755T1 (sl) 2019-02-28
EA201691920A1 (ru) 2017-01-30
PT3122755T (pt) 2019-01-30
PH12016501903B1 (en) 2017-01-09
AR099867A1 (es) 2016-08-24
US20180127437A1 (en) 2018-05-10
JP6480949B2 (ja) 2019-03-13
EP3122755A1 (en) 2017-02-01
DK3122755T3 (en) 2019-02-18
TR201900735T4 (tr) 2019-02-21
AU2015237840B2 (en) 2019-06-20
TWI648282B (zh) 2019-01-21
CN106414458A (zh) 2017-02-15
CA2943098A1 (en) 2015-10-01
US9908898B2 (en) 2018-03-06
CY1121147T1 (el) 2020-05-29
EP3122755B1 (en) 2018-11-07
ES2707099T3 (es) 2019-04-02
ZA201606598B (en) 2017-11-29
IL247955A0 (en) 2016-11-30

Similar Documents

Publication Publication Date Title
EA033544B1 (ru) Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret)
MX2018011831A (es) Antagonistas solubles de receptor de c5aa(c5ar).
PH12016501440A1 (en) Novel heterocyclic compounds
PH12016501903B1 (en) Novel fused imidazobenzothiazole compounds
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
MX2017010477A (es) Compuestos triciclicos y usos de los mismos en medicina.
MX2016011632A (es) Derivados de azaspiro como antagonistas de trpm8.
TW201613567A (en) Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament
MY175854A (en) Novel quinolone derivatives
PH12017501830A1 (en) Novel pyridinium compounds
TW201613864A (en) Novel compounds
PH12017501816A1 (en) Azabensimidazoles and their use as amp a receptor modulators
GEP20207108B (en) Substituted 2,4 diamino-quinoline as new anticancer agents
MX367404B (es) Amidas de benzoxazinona como moduladores del receptor de mineralocorticoides.
NZ740041A (en) Tricyclic fused pyridin-2-one derivatives and their use as brd4 inhibitors
MX2017009292A (es) Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3.
MY157629A (en) Fused thiazolo and oxazolo pyrimidinones
IN2013MU00665A (es)
PH12017500323B1 (en) P38 map kinase inhibiting indanyl urea compounds
IN2014KO00191A (es)
IN2013MU03838A (es)

Legal Events

Date Code Title Description
FG Grant or registration